Association of Dry Eye Disease With Dyslipidemia and Statin Use.
Am J Ophthalmol
; 218: 54-58, 2020 10.
Article
en En
| MEDLINE
| ID: mdl-32413410
ABSTRACT
PURPOSE:
To determine whether an association exists between dry eye disease (DED) and statin use and/or dyslipidemia.DESIGN:
Retrospective, case-control study.METHODS:
Setting:
University of North Carolina (UNC)-affiliated healthcare facilities. STUDY POPULATION 72,931 patients seen at UNC ophthalmology clinics over a 10-year period. MAIN OUTCOMEMEASURES:
Odds ratios (ORs) calculated between DED and a history of low, moderate, or high-intensity statin use; and ORs calculated between DED and abnormal lipid panel values.RESULTS:
Total of 39,336 individuals (53.9% female) were analyzed after exclusion of individuals with confounding risk factors for DED. Of these, 3,399 patients (8.6%) carried a diagnosis of DED. Low-, moderate-, and high-intensity statin regimens were used by 751 subjects (1.9%), 2,655 subjects (6.8%), and 1,036 subjects (2.6%). Lipid abnormalities were identified as total cholesterol >200 mg/dL, 4,558 subjects (11.6%); high-density lipoprotein (HDL) <40 mg/dL, 2,078 subjects (5.3%); low-density lipoprotein (LDL) >130 mg/dL, 2,756 subjects (7.0%); and triglycerides (TGs) >150 mg/dL, 2,881 subjects (7.3%). The odds ratios (OR) of carrying a diagnosis of DED given the presence of low-, moderate-, and high-intensity statin use were 1.39 (95% confidence interval [CI] 1.13-1.72); OR 1.47 (95% CI 1.30-1.65), and OR 1.46 (95% CI 1.21-1.75), respectively. The OR of carrying a diagnosis of DED given the presence of total cholesterol >200 mg/dL, HDL <40 mg/dL, LDL >130 mg/dL, and TGs >150 mg/dL were 1.66 (95% CI 1.52-1.82), 1.45 (95% CI 1.26-1.67), 1.55 (95% CI 1.39-1.74), and 1.43 (95% CI 1.27-1.61), respectively.CONCLUSIONS:
A history of statin use or dyslipidemia is associated with an increased odds of having a DED diagnosis. Further studies are needed to determine whether statin use and/or dyslipidemia increases the risk of DED.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Síndromes de Ojo Seco
/
Inhibidores de Hidroximetilglutaril-CoA Reductasas
/
Dislipidemias
Límite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Am J Ophthalmol
Año:
2020
Tipo del documento:
Article